Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia

Journal of Pediatrics

Volumn 137, Issue 4, 2000, Pages 504-509

  Agostoni, Carlo ^a   Massetto, Nicoletta ^b   Biasucci, Giacomo ^b   Rottoli, Amilcare ^b   Bonvissuto, Milena ^b   Bruzzese, MariaGrazia ^b   Giovannini, Marcello ^b   Riva, Enrica ^b  

^a SAN PAOLO HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; LONG CHAIN FATTY ACID; PHENYLALANINE 4 MONOOXYGENASE; PLACEBO; POLYUNSATURATED FATTY ACID;

ARTICLE; BRAIN DEVELOPMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; HYPERPHENYLALANINEMIA; LIPID COMPOSITION; LIPID DIET; MALE; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; VISION;

EID: 0033765096     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.108398     Document Type: Article

References (30)

1. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC. The hyperphenylalaninemias. In: Scriver RC, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw-Hill; p. 1015-75.
2. Lands EM. Renewed questions about polyunsaturated fatty acids. Nutr Rev 1986;44:189-95.
3. Poge AP, Baumann K, Muller E, Leichsenring M, Schmidt H, Bremer HJ. Long-chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake. J Inherit Metab Dis 1998;21: 373-81.
4. Sanjurjo P, Perteagudo L, Rodriguez Soriano J, Vilaseca A, Campistol J. Polyunsaturated fatty acid status in patients with phenylhetonuria. J Inherit Metab Dis 1994;17:704-9.
5. Neuringer M, Connor WE. N-3 fatty acids in the brain and retina: evidence for their essentiality. Nutr Rev 1986; 44:285-94.
6. Bick U, Fahrendorf G, Ludolph AG, Vasallo P, Weglage J, Ullrich K. Disturbed myelination in patients with treated hyperphenylalaninemias: evaluation with magnetic resonance imaging. Eur J Pediatr 1991;150:185-9.
7. Korinthenberg R, Ullrich K, Fullenhemper F. Evoked potentials and electroencefalography in adolescents with phenylketonuria. Neuropediatrics 1988;19:175-8.
8. Medical Research Council Working Party on Phenylketonuria. Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Br Med J 1993;306:115-9.
9. Heird WC, Prager TC, Anderson RE. Docosahexaenoic acid and the development and function of infant retina. Curr Opin Lipidol 1997;8:12-6.
10. Uauy R, Birch D, Birch E, Tyson J, Hoffman D. Effect of dietary w-3 fatty acids on retinal function of very low birth weight neonates. Pediatr Res 1990;28:485-92.
11. Birch EE, Hoffman DR, Uauy R, Birch DG, Prestidge C. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res 1998; 44:201-9.
12. Carnovale E, Marletta L, Miuccio F. Tabelle di composizione degli alimenti. (Italian Food Composition Tables). National Institute of Nutrition, Rome, 1995.
13. Chow CK, editor. Fatty acids in foods and their health implications. New York: Marcel Dekker Inc; 1992.
14. Carlson SE, Cooke RJ, Werkman SH, Tolley EA. First year growth of preterm infants fed standard compared to marine oil n-3 supplemented formula. Lipids 1992;27:901-7.
15. Sinclair AJ, Mann NJ. Short-term diets rich in arachidonic acid influence plasma phospholipid polyunsaturated fatty acid levels and prostacyclin and thromboxane production in humans. J Nutr 1996;126:1110S-4S.
16. General Recommendations on dietary fats for human consumption. In: Galli C, Simopoulos A, editors. Dietary omega3 and omega6 fatty acids: biological effects and nutritional essentiality. New York: Plenum Publishing; 1989. p. 403.
17. Livelli di Assunzione Raccomandati di Energia e Nutrienti per la Popolazione Italiana. LARN. (Italian Recommended Dietary Allowances). 1996 Revision. Italian Society of Human Nutrition, Rome, 1996.
18. Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total hpids from animal tissues. J Biol Chem 1957;226:497-509.
19. Agostoni C, Trojan S, Bellù R, Bruzzese MG, Giovannini M. Developmental quotient at 24 months and fatty acid composition of diet in early infancy: a follow up study. Arch Dis Child 1997;76:421-4.
20. McCulloch DL, Taylor M, Whyte H. Visual evoked potentials and visual prognosis following perinatal asphyxia. Arch Ophthalmol 1991;109:229-33.
21. McCulloch DL, Skarf B. Development of the human visual system: monocular and binocular pattern VEP latency. Invest Ophthalmol Vis Sci 1991;32:2372-81.
22. Henderson RM, McCulloch DL, Herbert AM, Robinson PH, Tajlor MJ. Visual event-related potentials in children with phenylhetonuria. Acta Paediatr 2000;89:52-7.
23. Agostoni C, Riva E, Biasucci G, Luotti D, Bruzzese MG, Marangoni F, Giovannini. M. The effects of n-3 and n-6 polyunsaturated fatty acids on plasma lipids and fatty acids of treated phenylketonuric children. Prostaglandins Leukot Essent Fatty Acids 1995;53: 401-4.
24. Craig-Schmidt MC, Stieh KE, Lien EL. Retinal fatty acids of piglets fed docosahexaenoic and arachidonic acids from microbial sources. Lipids 1996;31:53-9.
25. Leuzzi V, Rinalduzzi S, Chiarotti F, Garzia P, Trasimeni G, Accornero N. Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical and neuroradiological (MRI) correlations. J Inher Metab Dis 1998;21: 351-64.
26. Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA. Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 1994;60:189-94.
27. Agostoni C, Trojan S, Bellù R, Riva E, Giovannini M. Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long-chain polyunsaturated fatty acids. Pediatr Res 1995;38:262-6.
28. Bennett MJ, Gayton AR, Rittey CDC, Hosking JP Juvenile neuronal ceroidlipofuscinosis: developmental progress after supplementation with polyunsaturated fatty acids. Dev Med Child Neurol 1994;36:630-8.
29. Kurlak LO, Stephenson TJ. Plausible explanations for the effects of long-chain polyunsaturated fatty acids in neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F148-54.
30. Slater SJ, Kelley MB, Yeager MD, Larkin J, Ho C, Stubbs CD. Polyunsaturation in cell membranes and lipid bilayers and its effects on membrane proteins. Lipids 1996;31:S189-92.